This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

RN1219

Pfizer Inc.

Drug Names(s): RN1219

Description: RN1219 is a monoclonal antibody that binds to amyloid beta in the plasma and effectively removes it from the brain. Amyloid beta is the putatative cause of Alzheimer's disease.

Deal Structure: RN1219 was discovered by Rinat. In 2006, Pfizer acquired Rinat.


RN1219 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug